Onderneming Cantabio Pharmaceuticals Inc. Other OTC
Aandelen
CTBO
US13808X2036
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gergely Tóth
FOU | Founder | 51 | 06-02-12 |
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22-05-15 |
Max Zhu
BRD | Director/Board Member | 42 | 01-01-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22-05-15 |
Gergely Tóth
FOU | Founder | 51 | 06-02-12 |
Max Zhu
BRD | Director/Board Member | 42 | 01-01-15 |
Johnny He
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 22 549 | 6 763 ( 29,99 %) | 0 | 29,99 % |
Bedrijfsgegevens
Cantabio Pharmaceuticals, Inc.
2225 East Bayshore Road Suite 200
94303, Palo Alto
+
http://www.cantabio.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+51,71% | 63,85 mld. | |
-2,50% | 41,83 mld. | |
+40,01% | 40,47 mld. | |
-10,22% | 27,17 mld. | |
+13,30% | 26,52 mld. | |
-21,51% | 18,69 mld. | |
+2,70% | 12,73 mld. | |
+22,07% | 12,11 mld. | |
+27,48% | 12,07 mld. |